ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 637731 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 637731; 2) Community: the network communities that were significantly associated with the response to NSC 637731; 3) Molecule: the relationships between components within communities and NSC 637731; 4) MDR: the compounds that were significantly associated with the NSC 637731.

NSC Compound Enrichment Correlation
NSC 174121 Methotrexate Derivative 0.0038671642008129 0.11388175
NSC 626433 3-Nitro-5-formylisoxazole 0.0038671642008129 0.24310607
NSC 666783 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(4-methoxy- phenyl)amino]methyl]-5-methyl-, 3/5 methanol 0.00386716420081295 0.065650965
NSC 686556 Benzo[g]quinoline-5,10-dione, 4-[2-(dimethylamino) ethenyl]- 0.00386716420081295 0.67431495
NSC 709341 Null 0.00411343439683531 0.42368752
NSC 741078 Selumetinib 0.00411343439683531 0.36431535
NSC 405029 Null 0.00423163567577548 0.26080203
NSC 618261 2H-1-Benzopyran, 6-methoxy-3-nitro-2-[2,2,2',2'-tetramethyl (4,4'-bi-1,3-dioxolan)-5-yl]- 0.00423163567577548 0.10970544
NSC 650594 Null 0.00423163567577551 0.14805243
NSC 661940 2-(2-chloroethoxy)naphthazarin 0.00423163567577551 0.60690193
Total:58  Current:8    [First] [Prev] [Next] [Last]